Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CABOTEGRAVIR”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Early research (Phase 1)Study completedNCT02059031
What this trial is testing

Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Early research (Phase 1)Study completedNCT00812318
What this trial is testing

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
ViiV Healthcare 45
Post-approval studies (Phase 4)Study completedNCT05514509
What this trial is testing

A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

Who this might be right for
HIV Infections
ViiV Healthcare 370
Not applicableUnknownNCT06319105
What this trial is testing

PathToScale: An Implementation Evaluation

Who this might be right for
Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP
Georgetown University 9,900
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT02411435
What this trial is testing

Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 15
Early research (Phase 1)Study completedNCT02478463
What this trial is testing

Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 19
Early research (Phase 1)Study completedNCT02354950
What this trial is testing

Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers

Who this might be right for
HIV Infections
ViiV Healthcare 16
Testing effectiveness (Phase 2)Study completedNCT02120352
What this trial is testing

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 309
Not applicableUnknownNCT05697289
What this trial is testing

Satisfaction of HIV-infected Patients Treated With Cabotegravir-rilpivirine Injectable Dual Therapy

Who this might be right for
HIV Infections
Assistance Publique - Hôpitaux de Paris 150
Large-scale testing (Phase 3)Study completedNCT05896748
What this trial is testing

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 94
Large-scale testing (Phase 3)Study completedNCT04542070
What this trial is testing

Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed

Who this might be right for
HIV Infections
ViiV Healthcare 687
Large-scale testing (Phase 3)Study completedNCT05896761
What this trial is testing

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 118
Testing effectiveness (Phase 2)Study completedNCT03497676
What this trial is testing

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Testing effectiveness (Phase 2)Study completedNCT03739996
What this trial is testing

Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Large-scale testing (Phase 3)Study completedNCT05601128
What this trial is testing

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Who this might be right for
HIV-1-infectionHIV InfectionsHIV I Infection
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 12
Not applicableLooking for participantsNCT06807736
What this trial is testing

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

Who this might be right for
HIV InfectionSexual and Reproductive Health
Desmond Tutu HIV Foundation 1,800
Large-scale testing (Phase 3)Looking for participantsNCT06694805
What this trial is testing

Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 332
Post-approval studies (Phase 4)Study completedNCT05549726
What this trial is testing

SEARCH CAB LA Dynamic Choice HIV Prevention Study Extension

Who this might be right for
HIV
University of California, San Francisco 984
Not applicableStudy completedNCT06643897
What this trial is testing

Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.

Who this might be right for
HIV-1-infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 13
Load More Results